Despite this, a key strength of our study is the demonstration that a well-established risk variant for one neurodegenerative disease (APOE ε4 in AD) also exerts a conserved molecularsignature across multiple neurodegenerative conditions. This evidence concerns the gene APOE and Alzheimer disease.